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302dosimetry for radiodiagnostics (2). It has been used
for personal dosimetry (as a replacement for ﬁlm
badges) and medical dosimetry for both radio-
therapy and radiodiagnostics (2,3). The dosimeters
(nanoDot, Landauer, Glenwood, Illinois) used in our
study are OSL based, small (1  1  0.2 cm3), envi-
ronmentally stable, and highly accurate and precise
within the exposures measured in the study (3).
Additionally, placing them under the XPF attenu-
ating cap (BLOXR Corp., Salt Lake City, Utah) made
them imperceptible to the research subjects and
enabled comparative data assessment between cra-
nial locations.
Although not a focus of this paper, the biological
effects of long-term, low-dose radiation exposure
including the stochastic and dose-dependent deter-
ministic effects on health care workers are well
established. In fact, Andreassi et al. (4) recently re-
ported that workers exposed to high medical radia-
tion in the cardiac catheterization laboratory had
increased left-sided carotid intima-media thickness
(CIMT) and reduced leukocyte telomere length. The
presence of a speciﬁc polymorphism of the DNA
repair gene XRCC3 Thr241Met, associated with
increased chromosomal DNA damage in workers
occupationally exposed to long-term ionizing radia-
tion, was also found to be more prevalent in high-
exposure workers and associated with increased
CIMT (4). Although the risk of occupational radia-
tion–induced brain malignancies has not been deter-
mined, this study (complete lifetime dosimetry
reconstruction: occupational exposure, 12.6  8.6
years; dose, 21.1  26.3 mSv) suggests that adverse
vascular and subcellular effects exist for the left
side of the head and neck region of operators at
case volumes that are within routine practice and
not 2.5 million.
The secondary objective of our study was to
determine whether a light-weight cap (nonlead
based) could help attenuate the cranial radiation
exposure to near ambient levels. The studied cap
met those objectives, and its use would be consistent
with the fundamental radiation safety principle of
keeping medical radiation “as low as reasonably
achievable.”Ryan R. Reeves, MD
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Aortic Valve Replacement
Increase the Risk of
Cerebral Embolization?We read with great interest the paper by Bijuklic et al.
(1) that reported an increased risk of cerebral embo-
lization with direct transcatheter aortic valve
replacement (TAVR) without preceding balloon aortic
valvuloplasty (BAV) using a balloon-expandable
TAVR system.
Although this is a thought-provoking study, we feel
that there are several issues. This is a small, retro-
spective series, and the 2 groups are not well-matched.
The direct TAVR group consists entirely of S3 valves,
whereas the BAV group were mostly Sapien XT valves.
These 2 valves have different characteristics: for
instance, the S3 valve has a smaller sheath and delivery
system, which increases the proportion of patients
who can be treated by the transfemoral approach and
means that the cohort of patients treated may be
different. To support this theory, there were higher
rates of atrial ﬁbrillation, diabetes mellitus, and hy-
pertension in the direct group, which are important
risk factors for stroke. The 13 S3 patients in the BAV
group had small valve areas or valve calcium, which
will introduce selection bias. The authors do not report
differences in valvular calciﬁcation.
We also feel that Figure 1 requires further clariﬁ-
cation. These data represent the most important
results of the paper, but it is only represented in chart
form, and the data are not included in the Results
section. It is also not clear whether the error bars
represent standard deviation or standard error of the
mean. Furthermore, the error bars are missing from
chart A.
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303Finally, the authors have only shown an associa-
tion between direct TAVR and an increased volume of
cerebral ischemic lesions. Because the overall number
of lesions is not increased, and given the aforemen-
tioned issues, we feel that a title stating that there is
an increased risk of cerebral embolization without
prior balloon valvuloplasty in TAVR is potentially
misleading.*Sonny Palmer, MBBS
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Valve Replacement Increase the
Risk of Cerebral Embolization?TABLE 1 Cerebral DW-MRI
TAVI With
BAV
(n ¼ 32)
TAVI Without
BAV
(n ¼ 55) p Value
Incidence, % 59.4 70.9 0.27
Number of ischemic lesions 1.8  2.4 2.2  2.7 0.39
Volume of ischemic lesions,
mm3
89.5  128.2 235.4  331.4 0.01
Values are mean  SD. The incidence in % is deﬁned as the number of patients
with cerebral ischemic lesions divided by the total number of the patients multi-
plied by 100.
BAV ¼ balloon aortic valvuloplasty; DW-MRI ¼ diffusion-weighted magnetic
resonance imaging; TAVR ¼ transcatheter aortic valve replacement.We thank Dr. Palmer and colleagues for their interest
in our work (1) and appreciate their comments.
As mentioned in the discussion section of our
paper, one major limitation of the study is the retro-
spective design with a small number of patients.
The Edwards SAPIEN 3 (Edwards Lifesciences,
Irvine, California) with its smaller proﬁle (16- and
18-F) may allow the treatment of patients with
smaller, more calciﬁed peripheral arteries compared
with the Edwards SAPIEN XT (18- and 21-F). Periph-
eral artery disease, however, which is the main limi-
tation for the transfemoral approach, was well
balanced between the 2 groups (21.8% in trans-
catheter aortic valve replacement [TAVR] with
balloon aortic valvuloplasty [BAV], 20.0% in TAVR
without BAV; p ¼ 0.75).
In Table 1, the baseline characteristics of patients
undergoing TAVR with BAV were compared with
TAVR without BAV. There was a numerical but not
statistically signiﬁcant difference in atrial ﬁbrillation
(28.1% vs. 34.5%; p ¼ 0.7), diabetes (15.6% vs. 27.3%;
p ¼ 0.7), and arterial hypertension (73.3% vs. 81.8%;p ¼ 0.3) between the 2 groups. These are known
risk factors for stroke but not necessarily for cerebral
ischemic lesions post-TAVR. In a recent study,
Samim et al. (2) analyzed risk factors for post-TAVR
cerebral diffusion weighted-magnetic resonance
imaging lesions in a cohort of 276 patients. Indepen-
dent predictors for the number or volume of cerebral
lesions were age, hyperlipidemia, post-dilation and
peak transaortic gradient. In our study, age in the
TAVR without BAV group was numerically even
lower (82.9  6.8 years vs. 83.8  5.2 years;
p ¼ 0.81) and hyperlipidemia was comparable (50%
vs. 50.9%; p ¼ 0.8). When patients with post-
dilation were excluded (5 of 87) from the analysis,
the difference in mean volume of ischemic lesions
between the 2 groups remained statistically signiﬁ-
cant (243.4  334.9 mm3 for TAVR without BAV and
79.7  117.4 mm3 for TAVR with BAV; p ¼ 0.006).
Thus, differences in baseline characteristic do not
seem to explain our ﬁndings.
Aortic and aortic valve calciﬁcation might affect the
cardiac magnetic resonance ﬁndings. Unfortunately,
we do not have data on the degree of aortic/valve
calciﬁcation. However, transthoracic echocardiogra-
phy data, including transvalvular gradient, effective
oriﬁce area, and mean transvalvular gradient, were
comparable in both groups.
Detailed data of the incidence, number, and
volume of ischemic lesions are found in Table 1.
We disagree that it would be appropriate to
change the title of our paper to “Increased Volume
of Cerebral Ischemic Lesions After Implantation of a
Balloon-Expandable Aortic Valve Without Prior
Balloon Valvuloplasty.” Indeed, former studies have
demonstrated that not lesion number but lesion
volume on diffusion-weighted magnetic resonance
imaging correlates signiﬁcantly with clinical
outcome ratings (3). This makes sense, because the
volume includes single large as well as multiple
smaller lesions.
